Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant Escherichia coli and Klebsiella pneumoniae colonization and infection

BACKGROUND: Colistin has been used for therapy of carbapenem-resistant Gram-negative infections in Thailand, especially carbapenem-resistant A. baumannii and P. aeruginosa, for more than 10 years. However, the prevalence of colistin-resistant A. baumannii or P. aeruginosa is still less than 5%. Coli...

Descripción completa

Detalles Bibliográficos
Autores principales: Wangchinda, W., Pati, N., Maknakhon, N., Seenama, C., Tiengrim, S., Thamlikitkul, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050733/
https://www.ncbi.nlm.nih.gov/pubmed/30026942
http://dx.doi.org/10.1186/s13756-018-0375-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050733/
https://www.ncbi.nlm.nih.gov/pubmed/30026942
http://dx.doi.org/10.1186/s13756-018-0375-4

Ejemplares similares